Stock Analysis, Dividends, Split History

WG / Willbros Group, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price0.15
Volume1,990,900.00
Market Cap ($M)9.80
Enterprise Value ($M)245.19
Book Value ($M)15.17
Book Value / Share0.24
Price / Book0.65
NCAV ($M)-127.55
NCAV / Share-2.02
Price / NCAV-0.08
Share Statistics
Common Shares Outstanding 63,221,610
Scoring Models
Piotroski F-Score1.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.40
Return on Assets (ROA)-0.30
Return on Equity (ROE)-0.80
Balance Sheet (mrq) ($M)
Assets349.04
Liabilities333.87
Quick Ratio0.68
Current Ratio0.69
Income Statement (mra) ($M)
Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price2,000,000.00
Contracts Revenue849,983,000.00
Disposal Group Including Discontinued Operation Revenue0.00
Operating Income-91.34
Net Income-108.09
Earnings Per Share Diluted-1.74
Earnings Per Share Basic-1.74
Cash Flow Statement (mra) ($M)
Cash From Operations-51.47
Cash from Investing2.58
Cash from Financing2.58
Identifiers and Descriptors
CUSIP969203108
Central Index Key (CIK)1449732
Related CUSIPS
969199108 969203908 969203958

Split History

Stock splits are used by Willbros Group, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

REPH: Recro Pharma Analysis and Research Report

9h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

9h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

10h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...

Related News Stories

9.6% Dividend Yield And Trading 15% Below Book Value

2018-06-11 seekingalpha
CCT remains underleveraged and reported March 31 results just below my base case projections mostly due to lower-than-expected fee income but still covered its dividend by 97%. (37-3)

Mammoth Energy: Unsustainable Contract, Sum-Of-The-Parts Indicate 50% Downside

2018-04-24 seekingalpha
Sum of the parts and peer comps suggests 50%+ of value is due to its new T&D infrastructure business. (22-0)

Pipeline construction exec fights to stop bribery conviction barring him from Canada

2018-04-18 cbc.ca
The Texas-based vice-president of a company hoping to bid on Canadian pipeline projects wants to stop a hearing that could see him barred from crossing the border because of a past conviction for bribery. (13-0)

Primoris (PRIM) to Acquire Willbros, Boost MSA Revenues

2018-03-29 zacks
Primoris Services Corporation (PRIM - Free Report) recently entered into a definitive merger agreement to acquire Willbros Group, Inc. — a specialty energy infrastructure contractor — for an enterprise value of about $100 million. The buyout will strengthen Primoris’ business and boost revenues as well as profitability. About Willbros Headquartered in Houston, TX, Willbros serves the oil & gas and power industries through three operating segments — Utility Transmission and Distribution (“UTD”), Oil & Gas and Canada. (7-0)

BRIEF-Willbros Group Says Upon Termination Of Merger, Co To Pay Primoris Fee Of $4.3 Million

2018-03-28 reuters
* WILLBROS GROUP SAYS UPON TERMINATION OF MERGER IN CERTAIN CIRCUMSTANCES, CO TO PAY PRIMORIS FEE OF $4.3 MILLION - SEC FILING (7-1)

Silicon Investor Message Boards

This table lists all message boards related to WG / Willbros Group, Inc. on message board site Silicon Investor.

Great Western Minerals Grp Ltd (V.GWG) Great Western Minerals Grp Ltd (V.GWG) Great Western Minerals Grp Ltd (V.GWG) Tower Group, Inc. (TWGP) Tower Group, Inc. (TWGP) Tower Group, Inc. (TWGP)
Dawgu0027s Place Dawgu0027s Place Dawgu0027s Place WorldGate Communications, Inc. (WGAT) WorldGate Communications, Inc. (WGAT) WorldGate Communications, Inc. (WGAT)
KWG Resources (KWG - T) KWG Resources (KWG - T) KWG Resources (KWG - T) Hydro WGC Hydro WGC Hydro WGC
WGC-5 WGC-5 WGC-5 WGC-4 WGC-4 WGC-4
WGC-3 WGC-3 WGC-3 EWG - IShares Germany ETF EWG - IShares Germany ETF EWG - IShares Germany ETF
CUSIP: 969203108